AZD6538 / AstraZeneca, Takeda - LARVOL DELTA

AstraZeneca showcases innovation in infectious disease protection at ESCMID Global 2025 (AstraZeneca Press Release) - "AstraZeneca will share new data across its Vaccines & Immune Therapies portfolio at the 2025 Congress of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID Global 2025) in Vienna, Austria, from 11-15 April 2025. With 13 abstracts, including two oral presentations and two late-breaking poster presentations, the Company will highlight progress in advancing novel immunisations against bacterial and viral infectious diseases and share real-world evidence showing the burden of respiratory viral infections and the continued need for protection."

Clinical data • Preclinical • Bronchiectasis • Infectious Disease • Influenza • Respiratory Diseases